Melanoma complicating treatment with natalizumab (tysabri) for multiple sclerosis

J Neurol. 2009 Oct;256(10):1771-2. doi: 10.1007/s00415-009-5200-9. Epub 2009 Jul 16.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Female
  • Humans
  • Melanoma / chemically induced*
  • Melanoma / surgery
  • Middle Aged
  • Multiple Sclerosis / drug therapy
  • Natalizumab
  • Randomized Controlled Trials as Topic
  • Skin Neoplasms / chemically induced*
  • Skin Neoplasms / surgery
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Natalizumab